Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)

Jódar Gimeno, José EstebanPolonsky, WilliamRéa, RosangelaWarren, MarkVilsbøll, TinaHakan Bloch, J.Vrazic, H.Lindeberg, StaffanBain, Stephen2021-05-062021-05-062018Jodar, E., Polonsky, W., Rea, R., Warren, M., Vilsboll, T., Hakan-Bloch, J., Vrazic, H., Lindberg, S., & Bain, S. C. (2018). Semaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6). Diabetologia, 61(S1), S372-S373.0012-186X1432-0428http://hdl.handle.net/11268/10013engDiabetes mellitus tipo 2Calidad de vidaSemaglutide improves health-related quality of life vs placebo when added to standard-of care in patients with type 2 diabetes at high risk (SUSTAIN 6)conference outputrestricted accessMedicina preventivaEnfermedad cardiovascular